INMUNE BIO INC. Cash and Cash Equivalents
INMUNE BIO INC. (INMB) had Cash and Cash Equivalents of $24.75 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-03-30
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $24.75M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $27.73M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $33.37M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $19.34M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-12-31 | $24.75M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $27.73M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $33.37M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $19.34M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $20.92M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $33.55M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $31.07M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $26.00M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $35.85M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $41.81M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $47.83M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $51.00M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $52.15M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $57.41M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $61.21M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $66.73M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $74.81M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $84.47M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $39.52M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $45.34M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $21.97M 10-K · filed 2022-03-03 | $21.97M 10-K · filed 2021-03-04 |
| 2020-09-30 | $24.31M 10-Q · filed 2021-11-03 | $24.31M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.82M 10-Q · filed 2021-08-04 | $4.82M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $5.93M 10-Q · filed 2021-05-05 | $5.93M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $7.00M 10-K · filed 2022-03-03 | $7.00M 10-K · filed 2020-03-11 |
| 2019-09-30 | $7.38M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $9.36M 10-Q · filed 2020-08-05 | |
| 2019-03-31 | $6.05M 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $186.20K 10-K · filed 2021-03-04 | |
| 2018-09-30 | $650.86K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $1.11M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $1.96M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $1.37M 10-K · filed 2020-03-11 | |
| 2016-12-31 | $141.66K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |